ReviewBiomedical engineering letters2025
Advances in cardiovascular signal analysis with future directions: a review of machine learning and deep learning models for cardiovascular disease classification based on ECG, PCG, and PPG signals.
Review in Biomedical engineering letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Wearable Devices and Machine Learning in Cardiovascular Monitoring: Current Evidence and Future Directions for Precision Medicine.Journal of personalized medicine · 2026Review
- Wearable Flexible Sensors for Cardiovascular Disease Monitoring.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Weaving Intelligence: Thermally Drawn Multimaterial Fibers Toward AI-Enabled Smart Textiles.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Machine learning-enabled ECG arrhythmia classification: a systematic and educational study from signal processing to decision support.Scientific reports · 2026Article
- Minority class-aware multiclass arrhythmia detection using conditional GAN augmentation.Scientific reports · 2026Article
- The Evolving Role of Artificial Intelligence and Machine Learning in the Wearable Electrocardiogram: A Primer on Wearable-Enabled Prediction of Cardiac Dysfunction.Bioengineering (Basel, Switzerland) · 2026Review
- Multi class photoplethysmography-based deep model for cardiovascular disease classification.PloS one · 2026Article
- Phonocardiopulmography: the future of perioperative auscultation.Anesthesia and pain medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review examines the transformative impact of artificial intelligence (AI), including machine learning (ML) and deep learning (DL), on cardiovascular signal analysis, focusing on electrocardiograms (ECG), phonocardiograms (PCG), and photoplethysmograms (PPG). It evaluates state-of-the-art methodologies that enhance diagnostic accuracy and predictive analytics by leveraging AI-driven systems. A wide range of public and private datasets are assessed, with attention to their strengths and limitations in supporting cardiovascular diagnostics. Key preprocessing techniques, such as noise reduction, signal normalization, and artifact mitigation, are explored for their role in improving signal quality. The review also highlights feature extraction methods, from time-domain and frequency-domain analyses to advanced morphological and spectral approaches, which contribute to robust classifier performance. Traditional ML models, such as K-Nearest Neighbor (KNN), Support Vector Machines (SVM) and Random Forests (RF), are compared with advanced DL architectures, including Convolutional Neural Networks (CNNs), Long Short-Term Memory networks (LSTMs), and transfer learning models for detecting cardiovascular diseases. Despite these advancements, challenges such as dataset heterogeneity, preprocessing variability, and computational complexity persist, hindering clinical adoption. The review underscores the importance of large-scale, diverse datasets, multi-modal signal integration, and explainable AI to foster clinical trust and facilitate ethical deployment. By addressing these challenges, this review highlights the potential of AI to revolutionize cardiovascular healthcare through early diagnosis, wearable technology, and real-time decision support, paving the way for precision medicine and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.